2018 Q4 Form 10-K Financial Statement

#000143774920006517 Filed on March 30, 2020

View on sec.gov

Income Statement

Concept 2018 Q4 2018 2017 Q4
Revenue $1.410M $8.934M $2.370M
YoY Change -40.51% -16.04% 68.09%
Cost Of Revenue $940.0K $6.791M $1.730M
YoY Change -45.66% -17.44% 69.61%
Gross Profit $470.0K $2.143M $640.0K
YoY Change -26.56% -11.29% 68.42%
Gross Profit Margin 33.33% 23.99% 27.0%
Selling, General & Admin $510.0K $1.745M $570.0K
YoY Change -10.53% -19.85% 7.55%
% of Gross Profit 108.51% 81.45% 89.06%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $9.757K $10.00K
YoY Change -100.0% -42.3% 0.0%
% of Gross Profit 0.0% 0.46% 1.56%
Operating Expenses $520.0K $1.745M $560.0K
YoY Change -7.14% -19.85% 5.66%
Operating Profit -$50.00K -$62.35K $80.00K
YoY Change -162.5% -126.22% -153.33%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $11.31K $0.00
YoY Change 30.15%
Pretax Income -$40.00K -$51.03K $80.00K
YoY Change -150.0% -120.71% -157.14%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$40.00K -$51.03K $80.00K
YoY Change -150.0% -120.71% -157.14%
Net Earnings / Revenue -2.84% -0.57% 3.38%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.04 $0.07
COMMON SHARES
Basic Shares Outstanding 11.20M
Diluted Shares Outstanding 11.20M

Balance Sheet

Concept 2018 Q4 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.960M $1.964M $2.730M
YoY Change -28.21% -28.1% 43.68%
Cash & Equivalents $1.964M $1.964M $2.732M
Short-Term Investments
Other Short-Term Assets $37.61K $393.5K $370.0K
YoY Change -89.84% 6.75% -43.94%
Inventory
Prepaid Expenses
Receivables $652.8K $652.8K $620.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.010M $3.010M $3.720M
YoY Change -19.08% -19.02% 0.0%
LONG-TERM ASSETS
Property, Plant & Equipment $7.147K $7.150K $10.00K
YoY Change -28.53% -35.76% -66.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.281K $6.280K $10.00K
YoY Change -37.19% 0.0% 0.0%
Total Long-Term Assets $13.43K $13.43K $10.00K
YoY Change 34.28% -22.86% -66.67%
TOTAL ASSETS
Total Short-Term Assets $3.010M $3.010M $3.720M
Total Long-Term Assets $13.43K $13.43K $10.00K
Total Assets $3.024M $3.024M $3.730M
YoY Change -18.93% -19.04% -0.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.29K $25.29K $50.00K
YoY Change -49.41% -46.94% 0.0%
Accrued Expenses $300.0K $299.2K $690.0K
YoY Change -56.52% -56.45% 15.0%
Deferred Revenue $318.6K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.151M $1.151M $1.840M
YoY Change -37.44% -37.47% -13.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.151M $1.151M $1.840M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.151M $1.151M $1.840M
YoY Change -37.44% -37.47% -13.21%
SHAREHOLDERS EQUITY
Retained Earnings -$12.00M
YoY Change
Common Stock $128.4K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $930.2K
YoY Change
Treasury Stock Shares $1.643M
Shareholders Equity $1.873M $1.873M $1.894M
YoY Change
Total Liabilities & Shareholders Equity $3.024M $3.024M $3.730M
YoY Change -18.93% -19.04% -0.53%

Cashflow Statement

Concept 2018 Q4 2018 2017 Q4
OPERATING ACTIVITIES
Net Income -$40.00K -$51.03K $80.00K
YoY Change -150.0% -120.71% -157.14%
Depreciation, Depletion And Amortization $0.00 $9.757K $10.00K
YoY Change -100.0% -42.3% 0.0%
Cash From Operating Activities -$80.00K -$763.5K $180.0K
YoY Change -144.44% -191.32% -120.0%
INVESTING ACTIVITIES
Capital Expenditures $10.00K $5.771K $0.00
YoY Change -787.02%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.720K $0.00
YoY Change 89.01%
Cash From Investing Activities $0.00 -$4.052K $0.00
YoY Change -5888.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -80.00K -763.5K 180.0K
Cash From Investing Activities 0.000 -4.052K 0.000
Cash From Financing Activities
Net Change In Cash -80.00K -767.6K 180.0K
YoY Change -144.44% -191.8% -120.0%
FREE CASH FLOW
Cash From Operating Activities -$80.00K -$763.5K $180.0K
Capital Expenditures $10.00K $5.771K $0.00
Free Cash Flow -$90.00K -$769.3K $180.0K
YoY Change -150.0% -191.92% -120.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0000803578
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11211760
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 dei Entity Public Float
EntityPublicFloat
1425274
CY2019 dei Entity Registrant Name
EntityRegistrantName
INFORMATION ANALYSIS INC
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Security12g Title
Security12gTitle
Common Stock, par value $0.01 per share
CY2019Q4 iaic Accounts Receivable Allowance For Credit Loss Discounts
AccountsReceivableAllowanceForCreditLossDiscounts
0
CY2019Q4 iaic Accrued Accounting And Auditing Expense
AccruedAccountingAndAuditingExpense
47000
CY2018Q4 iaic Accrued Accounting And Auditing Expense
AccruedAccountingAndAuditingExpense
48750
CY2019Q4 iaic Accrued Costs Of Software Sales
AccruedCostsOfSoftwareSales
CY2018Q4 iaic Accrued Costs Of Software Sales
AccruedCostsOfSoftwareSales
13500
CY2019 iaic Benefit From Utilization Of Net Operating Losses
BenefitFromUtilizationOfNetOperatingLosses
CY2018 iaic Benefit From Utilization Of Net Operating Losses
BenefitFromUtilizationOfNetOperatingLosses
CY2019Q4 iaic Credit With Software Supplier
CreditWithSoftwareSupplier
57
CY2018Q4 iaic Credit With Software Supplier
CreditWithSoftwareSupplier
37557
CY2019 iaic Current Federal State And Local And Other Tax Expense Benefit
CurrentFederalStateAndLocalAndOtherTaxExpenseBenefit
CY2018 iaic Current Federal State And Local And Other Tax Expense Benefit
CurrentFederalStateAndLocalAndOtherTaxExpenseBenefit
CY2019Q4 iaic Deferred Costs Of Software Sales
DeferredCostsOfSoftwareSales
453607
CY2018Q4 iaic Deferred Costs Of Software Sales
DeferredCostsOfSoftwareSales
294115
CY2019 iaic Effective Income Tax Rate Reconciliation Nol Expirations Amount
EffectiveIncomeTaxRateReconciliationNOLExpirationsAmount
1302000
CY2018 iaic Effective Income Tax Rate Reconciliation Nol Expirations Amount
EffectiveIncomeTaxRateReconciliationNOLExpirationsAmount
2015100
CY2019 iaic Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
2900
CY2018 iaic Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
8600
CY2019Q4 iaic Operating Loss Carryforwards Subject To Expiration
OperatingLossCarryforwardsSubjectToExpiration
2200000
CY2019Q4 iaic Other Accrued Liabilities Other Current
OtherAccruedLiabilitiesOtherCurrent
7257
CY2018Q4 iaic Other Accrued Liabilities Other Current
OtherAccruedLiabilitiesOtherCurrent
19235
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
216227
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25294
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
668712
CY2018Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
652839
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
668712
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
652839
CY2019Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
108058
CY2018Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
508083
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
300258
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
294424
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14682937
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14676006
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29600
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6031
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6031
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29600
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2019Q4 us-gaap Assets
Assets
2374041
CY2018Q4 us-gaap Assets
Assets
3023756
CY2019Q4 us-gaap Assets Current
AssetsCurrent
2208317
CY2018Q4 us-gaap Assets Current
AssetsCurrent
3010328
CY2019Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
0
CY2018Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
3480
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1039442
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1963956
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2731510
CY2019 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-924514
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-767554
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12854376
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12844376
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11211760
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11201760
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
128543
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
128443
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-717246
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51034
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Concentration of Credit Risk</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div>the Company&#x2019;s prime contracts with U.S. government agencies represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76.8%</div> of revenue, subcontracts under federal procurements represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23.0%</div> of revenue, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.2%</div> of revenue came from commercial contracts. The terms of these contracts and subcontracts vary from single transactions to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years. Within this group of prime contracts with U.S. government agencies, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> individual contract represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19.0%</div> of revenue. One subcontract under a federal procurement represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17.2%</div> of revenue.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">In the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>the Company&#x2019;s prime contracts with U.S. government agencies represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">68.8%</div> of revenue, subcontracts under federal procurements represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26.5%</div> of revenue, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.7%</div> of revenue came from commercial contracts, and less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.05%</div> of revenue came from state and local government contracts. The terms of these contracts and subcontracts vary from single transactions to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years. Within this group of prime contracts with U.S. government agencies, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> individual contracts represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20.5%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12.4%</div> of revenue, respectively. One subcontract under a federal procurement represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22.1%</div> of revenue.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"></div></div></div></div></div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">The Company sold <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div>-party software and maintenance contracts under agreements with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> major supplier in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> accounting for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">67.1%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50.0%</div> of total revenue, respectively.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div>the Company&#x2019;s accounts receivable included receivables from prime contracts with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> U.S. government agencies that represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13.0%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.7%</div> of the Company&#x2019;s outstanding accounts receivable, respectively, and receivables from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> subcontract under a federal procurement that represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">43.2%</div> of the Company&#x2019;s outstanding accounts receivable.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>the Company&#x2019;s accounts receivable included receivables from prime contracts with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> U.S. government agencies that represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16.6%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16.3%</div> of the Company&#x2019;s outstanding accounts receivable, respectively, and receivables from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> subcontract under a federal procurement that represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44.3%</div> of the Company&#x2019;s outstanding accounts receivable.</div></div></div></div></div></div>
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
464223
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
318552
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
8765002
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
6790937
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
926600
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2043700
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
916200
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1934300
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3700
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6400
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
23500
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
24100
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
21200
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
24500
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
9000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
102600
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
926600
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2043700
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
32162
CY2018 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
30599
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2018 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.25
CY2018 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.25
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5834
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9757
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5834
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9757
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
219350
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
217751
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
781
CY2019 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P90D
CY2019 us-gaap Gross Profit
GrossProfit
1399979
CY2018 us-gaap Gross Profit
GrossProfit
2142838
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-717246
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51034
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-150600
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10700
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-1300
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-1900
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-35900
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2600
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7200
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
190933
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-22364
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15963
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
37125
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
CY2018 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-6400
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-727787
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-62345
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-17088
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-387833
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
145671
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-68450
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
115383
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24907
CY2019 us-gaap Increase Decrease In Reserve For Commissions Expense And Taxes
IncreaseDecreaseInReserveForCommissionsExpenseAndTaxes
400025
CY2018 us-gaap Increase Decrease In Reserve For Commissions Expense And Taxes
IncreaseDecreaseInReserveForCommissionsExpenseAndTaxes
204746
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2018 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2019 us-gaap Interest Paid Net
InterestPaidNet
CY2018 us-gaap Interest Paid Net
InterestPaidNet
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
104487
CY2019 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
104487
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
156519
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
110086
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
46433
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6969
CY2019Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P4Y30D
CY2019Q4 us-gaap Liabilities
Liabilities
1211665
CY2018Q4 us-gaap Liabilities
Liabilities
1151165
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2374041
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3023756
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1166070
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1151165
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8368
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4052
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-917146
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-763502
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-717246
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-51034
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-717246
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-51034
CY2019 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-717246
CY2018 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-51034
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
104487
CY2018 us-gaap Operating Lease Expense
OperatingLeaseExpense
104487
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
149550
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
103955
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
45595
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
149762
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y182D
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
3500000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
54257
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
81485
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
25708
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
37609
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6281
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6281
CY2019 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
10541
CY2018 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
11311
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8368
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5771
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
500163
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
393533
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
20791
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
15499
CY2019Q4 us-gaap Prepaid Rent
PrepaidRent
CY2018Q4 us-gaap Prepaid Rent
PrepaidRent
8753
CY2019 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
CY2018 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1719
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
309939
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
301571
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9681
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7147
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
90
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12718893
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12001647
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10164981
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8933775
CY2019 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
252511
CY2018 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
459863
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
148500
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
23500
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
5000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.21
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.20
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.17
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y335D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y302D
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1875255
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1745320
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
6031
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
29600
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.579
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0231
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
15500
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.11
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1376500
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1349000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.23
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.23
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1325500
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.23
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.10
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.10
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.46
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.21
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
123000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.20
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1162376
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1872591
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
1894025
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1642616
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1642616
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
930211
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
930211
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results can, and in many cases will, differ from those estimates.</div></div></div></div></div></div>
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1117100
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2008500
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11208308
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11201760
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11208308
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11201760

Files In Submission

Name View Source Status
0001437749-20-006517-index-headers.html Edgar Link pending
0001437749-20-006517-index.html Edgar Link pending
0001437749-20-006517.txt Edgar Link pending
0001437749-20-006517-xbrl.zip Edgar Link pending
ex_178816.htm Edgar Link pending
ex_178817.htm Edgar Link pending
ex_178818.htm Edgar Link pending
ex_178819.htm Edgar Link pending
ex_178820.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
iaic-20191231.xml Edgar Link completed
iaic-20191231.xsd Edgar Link pending
iaic-20191231_cal.xml Edgar Link unprocessable
iaic-20191231_def.xml Edgar Link unprocessable
iaic-20191231_lab.xml Edgar Link unprocessable
iaic-20191231_pre.xml Edgar Link unprocessable
iaic20191231_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending